PACT Pharma

PACT Pharma is a biopharmaceutical company dedicated to developing personalized T-cell therapies targeting neoantigens. PACT Pharma focuses on synthesizing drugs that target new epitopes and producing personalized adoptive cell therapies, aiming to benefit every cancer patient. The new epitope targeting is designed using the patient's own T-cells (autologous T-cells) to program them to seek, infiltrate, and kill tumor cells displaying unique neoepitopes.